Navigation Links
Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates
Date:1/9/2012

be submitted timely or receive FDA approval; risks that the information we provided in our response to the FDA's BYDUREON complete response letter may not satisfy the FDA; risks that the FDA may request additional information prior to approving BYDUREON; risks that we will not launch BYDUREON, if approved, in a timely or successful manner; risks that our efforts to expand the reach of our sales force will not produce the results we expect; risks that we will not be successful in our efforts to advance new forms and delivery options for exenatide or in our efforts to secure an exenatide commercial partner outside the U.S.; risks that we will not submit the remaining components of the BLA mentioned in this press release in a timely manner; risks that we will not initiate the Phase 3 programs mentioned in this press release in a timely manner; risks that our efforts to drive operational efficiencies, reduce operating costs and/or preserve cash will not produce the results we expect and other risks inherent in the drug development and commercialization process. Commercial and government reimbursement and pricing decisions and the pace of market acceptance may also affect the potential for BYETTA, BYDUREON or SYMLIN. These and additional risks and uncertainties are described more fully in the Company's recently filed Form 10-Q. Amylin disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Healthcare Conference
2. Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
3. Amylin Pharmaceuticals to Present at the Credit Suisse 2011 Healthcare Conference
4. Amylin Pharmaceuticals Reports Third Quarter Financial Results
5. Amylin Pharmaceuticals to Webcast Third Quarter Results
6. Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
8. Amylin Pharmaceuticals to Webcast Second Quarter Results
9. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
10. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
11. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of ... D 2015 enrollment data shows that 81 percent of ... access and extra discounts at certain pharmacies. The findings ... "Preferred pharmacy plans are now the foundation of Medicare ...
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced the ... the compounding, packaging and distributing of its naltrexone tablets.  The ... United States . KRS Global is ... tablets in various strengths for individual patients in response to ...
(Date:1/23/2015)... Idaho , Jan. 23, 2015  Now available for ... No. 7,849,611) support that prevents ankle sprains by cushioning ... brace, it fits securely around the outside of any ... mobility & comfort while still offering protection against sprains. ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Heygood, Orr & Pearson are announcing a Los Angeles Superior ... (NYSE: WPI ) and its subsidiary companies to ... lawsuit over the death of a 37-year-old woman who died while ... represents the parents of Nicole Bristol, who died on Feb. ...
... DIEGO, March 21, 2011 Marshall Edwards, Inc.(Nasdaq: ... clinical development of novel therapeutics targeting cancer metabolism, announced ... clinical trial of intravenous Phenoxodiol in combination with cisplatin ... now available on the International Journal of Gynecological ...
Cached Medicine Technology:Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit 2Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol 2Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol 3
(Date:1/22/2015)... Illinois (PRWEB) January 22, 2015 Deer Path ... will host a Valentine’s Day Happy Hour from 3 p.m. to ... at 12500 Regency Parkway in Huntley, Illinois, serves adults with physical ... Hour event will include Valentine's Day treats, games and sweetheart-themed karaoke. ...
(Date:1/22/2015)... California (PRWEB) January 22, 2015 The City of ... at 10 a.m., to commemorate the 42nd anniversary of the Supreme ... States. , “It’s been 42 years since the Roe vs. Wade ... is still as present as ever,” said City of West Hollywood ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently released ... website of AngelWeddingDress.com to find more details. , ... for a bridal party. AngelWeddingDress offers a variety of ... maternity wedding dresses are specially designed for 2015. , ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... therapy has always excited scientists, even after twenty years ... tame the evil ways of viruses, such as those ... have realized there is one stumbling block to this ... of an effective transport system, equipped to deliver therapeutic ...
... we shed tears. But exactly what our tears are made of ... sheds some light on the complex design of tears. What we ... up of three distinct, microscopic layers. The middle, watery layer – ... is sandwiched between a layer of mucus and an outer layer ...
... from a more advanced screening process allowing for a ... the plenary session today at the Multidisciplinary Head and ... the American Society for Therapeutic Radiology and Oncology, the ... and Neck Society. ,"By combining conventional techniques ...
... granted a whopping $8.1 million to develop a tool kit ... virus. This was announced by the National Institute of Allergy ... the Avian influenza or the H5N1 virus has the potential ... from the terrorists all over that there could be a ...
... finds that, winning a Nobel Prize adds almost two years ... the cash that accompanies the award.// ,Professor Andrew ... Rablen conducted a study on the effect of status on ... it becomes difficult to say which has more influence on ...
... giant, is finalizing its plan of action, to test its ... bid to establish the most effective vaccine against cervical cancer. ... United States, will seek to evaluate the immune responses of ... of the human papillomavirus. This virus is known to be ...
Cached Medicine News:Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 2Health News:Researchers Explore the Effect of Engineered Immune Cells on HIV 3Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 2Health News:Tears Reveal Some of Their Deepest Secrets to Researchers 3Health News:New Screening Process Helps Better Diagnose Oral Cancers 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: